MRD / Regn No. : 20180000476 Date : 27/06/2026
Patient Name : Nirmala Kodandan Age & Gender : 53 Yrs. / Female
Contact No. : 9840902871 UHID :
Ht / Wt / BMI : 155.5 / 82 / 33.91 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : VITAMIN D DEFICIENCY (01/Jan/2016) | HYPERTENSION (01/Jan/2014) | TYPE 2 DM (01/Jan/2015) |
Subjective : RESULT REVIEW
Objective : N
Analysis : TYPE 2 DM
Plan : MEDICATIONS AS PRESCRIBED,SEE ME IN 1 MONTH  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 238 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 10.3 % | POST PRANDIAL GLUCOSE (2HPP): 297 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TELMISARTAN - HCTZ 80 MG
TELMA H 80 MG 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
2 ROSUVASTATIN 10 MG
ROSEDAY 10 MG 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
3 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG 		SQ 16-0-12 UNITS BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
4 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
5 INJECTION SEMAGLUTIDE 0.5 MG
SEMALIX 0.5
Medicine For DIABETES OBESITY HEART KIDNEY PROTECTION 		SQ EVERY WEEK AS DIRECTED NO RELATION TO FOOD
MAY CAUSE NAUSEA CONSTIPATION OR VISUAL DISTURBANCE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 27/Jul/2026
Tests Suggested For Next Visit : FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: